LINC00917

Across TCGA pan-cancer cohorts, LINC00917 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC00917 data layer compared with 1 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC00917 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00917 expression acts as an unfavorable survival marker, although some lineages such as LUSC and HNSC show a favorable association.

COAD, BLCA, and LUSC are the cancer types where LINC00917 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	IV	0.214	0.524	<.001	78	view →
BLCA	OS	Tertile	IV	0.183	0.630	<.001	45	view →
LUSC	DFS	Tertile	II,III,IV	0.651	0.301	<.001	42	view →
HNSC	OS	Tertile	IV	0.863	0.681	.002	32	view →
ACC	DFS	Tertile	IV	0.010	0.383	<.001	27	view →
UCS	DFS	Tertile	IV	0.321	0.805	.012	18	view →
DLBC	OS	Tertile	III,IV	0.272	1.000	.017	16	view →
THCA	DFS	Tertile	II,III,IV	0.744	0.887	.024	15	view →
STAD	DFS	Tertile	All	0.500	0.737	.013	12	view →
CHOL	DFS	Median	III,IV	0.118	0.476	.031	6	view →
ESCA	DFS	Quartile	III,IV	0.640	0.257	.037	4	view →
UVM	DFS	Quartile	III,IV	0.783	0.478	.040	2	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LINC00917–COAD (DFS)

Open the COAD breakdown →